多发性硬化症患者疾病修饰药物变化的决定因素:基于注册表的研究
Sajjad Ghane Ezabadi1, Azadeh Ebrahimitirtashi1, Zahra Salehi2
1Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.
Multiple sclerosis and related disorders
|March 13, 2026
概括
疾病控制不足和药物不良反应是德黑兰改变多发性硬化症 (MS) 治疗的关键原因. 进展性多发性硬化症患者需要量身定制的疗法以获得更好的结果.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 多发性硬化症 (MS) 是一种主要的神经炎症性疾病,在伊朗德黑兰的发病率越来越高.
- 疾病修饰药物 (DMD) 对于治疗多发性硬化症至关重要,但会带来大量的医疗费用.
- 了解影响DMD变化的因素对于优化治疗和成本效益至关重要.
研究的目的:
- 在德黑兰的多发性硬化症患者中确定DMD治疗方案变化的主要原因.
- 探索与DMD修饰相关的人口和临床因素.
主要方法:
- 一项基于注册表的横截面研究,对2771名MS (PwMS) 患者进行了研究,这些患者在五年内改变了DMD.
- 分析了来自伊朗国家多发性硬化病登记处 (NMSRI) 的数据.
- 统计分析确定了变化的原因和相关因素 (P < 0.05).
主要成果:
- 超过70%的PwMS患者改变了他们的DMD疗法.
- 不充分的疾病控制/复发 (62.3%) 和不良药物反应 (30.7%) 是变化的主要驱动因素.
- 渐进式多发性硬化和初始运动功能障碍与更高的治疗修改率有关.
结论:
- 不充分的疾病控制和不良药物反应显著影响德黑兰MS患者的DMD变化.
- 渐进性多发性硬化症患者需要更有效的,个性化的治疗策略.
- 考虑到疾病严重程度和症状的个性化护理对于优化多发性硬化症治疗结果至关重要.
相关概念视频
01:29Therapeutic Drug Monitoring: Affecting Factors
313
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
313
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
93
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
93
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
637
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
637
01:25Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
334
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
334
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
63
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
63
01:21Factors Affecting Drug Response: Overview
3.2K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.2K